UK Markets closed

Adicet Bio, Inc. (0HX7.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
14.14+1.42 (+11.13%)
At close: 02:56PM BST
Full screen
Previous close12.73
Open14.14
Bid0.00 x N/A
Ask0.00 x N/A
Day's range14.14 - 14.14
52-week range14.14 - 14.14
Volume73
Avg. volumeN/A
Market cap728.561M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
EPS (TTM)-2.01
Earnings date09 Mar 2022 - 14 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Adicet Bio to Present at Upcoming Investor Conferences

    REDWOOD CITY, Calif. & BOSTON, June 21, 2022--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antigen receptor (CAR) T cell therapies for cancer, today announced that company management will participate in two upcoming investor conferences in June.

  • Business Wire

    Adicet Bio Reports Emerging Data from ADI-001 Phase 1 Trial at the American Society of Clinical Oncology Annual Meeting

    REDWOOD CITY, Calif. & BOSTON, June 06, 2022--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing first-in-class allogeneic gamma delta chimeric antigen receptor (CAR) T cell therapies for cancer, today announced emerging positive safety and efficacy data from the Company’s Phase 1 study of ADI-001 for the potential treatment of relapsed or refractory B-cell Non-Hodgkin’s Lymphoma (NHL) in an oral presentation at the 2022 American Society of Clinica

  • Business Wire

    Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

    MENLO PARK, Calif. & BOSTON, June 03, 2022--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell therapies for cancer, today announced it granted inducement awards on May 31, 2022 (the "Grant Date") under Adicet’s 2022 Inducement Plan as a material inducement to employment to four individuals hired by Adicet in May 2022.